A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers.

被引：0
|
作者：
Gebbia, N
Verderame, F
Di Leo, R
Santangelo, D
Cicero, G
Valerio, MR
Arcara, C
Badalamenti, G
Fulfaro, F
Carreca, I
机构：
[1] Dept Oncol, Palermo, Sicily, Italy
[2] Azienda Osp, Sciacca, Italy
[3] Dept Expt & Clin Onc, Palermo, Sicily, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：340S / 340S
页数：1
相关论文
共 50 条
  • [11] Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers
    Jensen, Lars H.
    Andersen, Rikke Fredslund
    Byriel, Lene
    Fernebro, Eva
    Jakobsen, Anders
    Lindebjerg, Jan
    Nottelmann, Lise
    Ploen, John
    Hansen, Torben F.
    ACTA ONCOLOGICA, 2020, 59 (03) : 298 - 301
  • [12] Prospective Phase II Trial of Gemcitabine in Combination with Irinotecan as First-Line Chemotherapy in Patients with Advanced Biliary Tract Cancer
    Chung, Moon Jae
    Kim, Yoon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Song, Si Young
    Chung, Jae Bock
    Park, Seung Woo
    CHEMOTHERAPY, 2011, 57 (03) : 236 - 243
  • [13] Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
    Thongprasert, S
    Napapan, S
    Charoentum, C
    Moonprakan, S
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 279 - 281
  • [14] Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract Carcinoma
    Hollebecque, Antoine
    Bouche, Olivier
    Romano, Olivier
    Scaglia, Elodie
    Cattan, Stephane
    Zerbib, Philippe
    Heurgue, Alexandra
    Lagarde, Stephanie
    Mariette, Christophe
    Triboulet, Jean-Pierre
    Pruvot, Francois-Rene
    Hebbar, Mohamed
    CHEMOTHERAPY, 2010, 56 (03) : 234 - 238
  • [15] Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study
    Williams, Kerry J.
    Picus, Joel
    Trinkhaus, Kim
    Fournier, Chloe C.
    Suresh, Rama
    James, Joan S.
    Tan, Benjamin R.
    HPB, 2010, 12 (06) : 418 - 426
  • [16] A Phase II Study of Outpatient Biweekly Gemcitabine-Oxaliplatin in Advanced Biliary Tract Carcinomas
    Halim, Amal
    Ebrahim, Mohamed Awad
    Saleh, Yaser
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (02) : 217 - 224
  • [17] Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer
    Pressiani, Tiziana
    Balsano, Rita
    Giordano, Laura
    Milella, Michele
    Bergamo, Francesca
    Bozzarelli, Silvia
    Noventa, Silvia
    Ferrrari, Daris
    Scartozzi, Mario
    Parra, Hector Soto
    Auriemma, Alessandra
    Solda, Caterina
    Zaniboni, Alberto
    Zecchetto, Camilla
    Rizzato, Mario Domenico
    Rimassa, Lorenza
    Santoro, Armando
    EUROPEAN JOURNAL OF CANCER, 2024, 207
  • [18] Biomarker analysis of first-line sintilimab plus gemcitabine and cisplatin in patients with advanced biliary tract cancers: Results from a phase II study.
    Yuan, Zhen-Gang
    Zeng, Tian-Mei
    Tao, Chen-Jie
    Yang, Guang
    Xu, He-Ming
    Wei, Wei
    Chen, Xi-Yun
    Cheng, Zhuo
    Dong, Yu-Long
    Shang, Pei-Pei
    Lou, Cheng
    Han, Qin
    Chen, Dong-Sheng
    Song, Yunjie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16189 - E16189
  • [19] Phase Ib study of gemcitabine and oxaliplatin with erlotinib in patients with advanced biliary tract cancer.
    Ciombor, Kristen Keon
    Cardin, Dana Backlund
    Chan, Emily
    McClanahan, Pamela
    Fan, Kang-Hsien
    Flynn, Jayme
    Young, Ruth T.
    DeMers, April
    Smith, Stephen James
    Berlin, Jordan
    Goff, Laura Williams
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [20] Chemotherapy with gemcitabine as first-line treatment for advanced biliary tract carcinoma
    Giacobino, A.
    Satolli, M. A.
    Dongiovanni, D.
    Rahimi, F.
    Milanesi, E.
    Zanini, M.
    Scigliano, M. C.
    Monge, T.
    Ceccarelli, M.
    Novarino, A.
    Ciorba, A.
    Manazza, A.
    Bertetto, O.
    Ciuffreda, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 16 - 16
12345